Does topical application of tranexamic acid reduce intraoperative bleeding in sinus surgery during general anesthesia?
Haram Kang, Se Hwan Hwang
https://pubmed.ncbi.nlm.nih.gov/31653606Actively Recruiting
Led by Assiut University · Updated on 2025-01-29
90
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are studying the effects of preoperative intravenous and nebulized tranexamic acid on patients undergoing functional endoscopic sinus surgery (FESS), a common treatment for conditions affecting the nasal cavity and paranasal sinuses. The study aims to assess how these treatments impact surgical field visibility using the Modena Bleeding Score, blood loss, anesthetic use, and patient hemodynamics. It also monitors potential postoperative complications such as nausea, vomiting, visual disturbances, seizures, and clotting events. Participants will receive either intravenous or nebulized tranexamic acid before surgery to compare their effects on controlling bleeding during FESS. Tranexamic acid works by inhibiting fibrinolysis, which helps reduce bleeding. The study evaluates the two methods of administration to determine which better improves the surgical experience for both surgeons and patients. Throughout the study, participants' vital signs like blood pressure, respiratory rate, temperature, pulse, oxygen saturation, and end-tidal CO2 will be monitored. Researchers will measure intraoperative bleeding by blood volume collected and gauze count, track anesthetic consumption including extra doses of fentanyl, propofol, and sevoflurane, and observe any postoperative complications. The trial includes regular assessments to evaluate safety and effectiveness, with participation lasting through the surgical procedure and immediate recovery period.
CONDITIONS
Assessment of Nebulized Tranexamic Acid in Functional Endoscopic Sinus Surgery Using Modena Bleeding Score
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Surgery day
Participants receive nebulized or intravenous tranexamic acid during functional endoscopic sinus surgery to control blood loss and improve surgical conditions.
1 visit (in-person, surgery day)
Duration - Post-surgery recovery period
Participants are monitored for post-operative complications such as nausea, vomiting, and visual disturbances following surgery.
Approximately 1 follow-up visit
Total: 1 location
1
Main building, Assiut University Hospitals
Asyut, Egypt
Actively Recruiting
A
Asmaa Shabaan Zanaty, Doctor
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Haram Kang, Se Hwan Hwang
https://pubmed.ncbi.nlm.nih.gov/31653606Akhil J Khosla, Francisco G Pernas, Patricia A Maeso
https://pubmed.ncbi.nlm.nih.gov/23255493Do Hyun Kim, Subin Kim, Haram Kang...
https://pubmed.ncbi.nlm.nih.gov/30593688Matteo Alicandri-Ciufelli, Luca Pingani, Davide Mariano...
https://pubmed.ncbi.nlm.nih.gov/30604058